C

Cellivery Therapeutics Inc
KOSDAQ:268600

Watchlist Manager
Cellivery Therapeutics Inc
KOSDAQ:268600
Watchlist
Price: 6 680 KRW -29.91% Market Closed
Market Cap: 245B KRW
Have any thoughts about
Cellivery Therapeutics Inc?
Write Note

Income Statement

Earnings Waterfall
Cellivery Therapeutics Inc

Revenue
24.5B KRW
Cost of Revenue
-24B KRW
Gross Profit
563.7m KRW
Operating Expenses
-15.5B KRW
Operating Income
-14.9B KRW
Other Expenses
8.8B KRW
Net Income
-6.1B KRW

Income Statement
Cellivery Therapeutics Inc

Rotate your device to view
Income Statement
Currency: KRW
Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
4 512
N/A
3 539
-22%
2 461
-30%
2 717
+10%
2 074
-24%
1 776
-14%
1 197
-33%
917
-23%
762
-17%
679
-11%
455
-33%
367
-19%
3 872
+954%
11 896
+207%
16 604
+40%
21 276
+28%
23 158
+9%
15 871
-31%
11 926
-25%
7 262
-39%
18 863
+160%
21 998
+17%
22 685
+3%
24 536
+8%
Gross Profit
Cost of Revenue
(2 996)
(2 881)
(3 372)
(3 022)
(3 976)
(3 668)
(3 184)
(2 831)
(1 485)
(1 287)
(834)
(472)
(3 802)
(10 464)
(14 615)
(19 132)
(23 427)
(17 566)
(14 211)
(10 507)
(18 673)
(21 994)
(22 437)
(23 972)
Gross Profit
1 517
N/A
658
-57%
(911)
N/A
(305)
+66%
(1 902)
-523%
(1 892)
+1%
(1 987)
-5%
(1 914)
+4%
(724)
+62%
(608)
+16%
(380)
+37%
(105)
+72%
71
N/A
1 432
+1 927%
1 989
+39%
2 144
+8%
(269)
N/A
(1 695)
-530%
(2 285)
-35%
(3 245)
-42%
190
N/A
4
-98%
249
+6 226%
564
+127%
Operating Income
Operating Expenses
(5 619)
(2 185)
(6 170)
(10 956)
(12 682)
(13 577)
(14 596)
(15 464)
(16 888)
(17 567)
(19 954)
(24 011)
(28 121)
(40 452)
(46 139)
(53 404)
(66 623)
(55 994)
(50 779)
(35 947)
(19 757)
(21 751)
(18 578)
(15 495)
Selling, General & Administrative
(4 703)
(5 246)
(6 256)
(7 397)
(7 734)
(8 414)
(8 147)
(8 802)
(10 300)
(10 955)
(14 555)
(16 184)
(18 993)
(29 234)
(33 983)
(40 859)
(43 274)
(32 944)
(22 897)
(12 532)
(8 848)
(10 715)
(11 686)
(11 364)
Research & Development
(410)
(691)
(1 997)
(2 800)
(3 975)
(4 240)
(5 530)
(5 772)
(5 697)
(5 678)
(4 387)
(6 727)
(7 708)
(9 273)
(9 505)
(9 098)
(19 115)
(19 586)
(23 725)
0
(6 946)
(7 695)
0
(2 078)
Depreciation & Amortization
(506)
(671)
(757)
(878)
(973)
(922)
(918)
(890)
(891)
(933)
(1 012)
(1 100)
(1 343)
(1 947)
(2 651)
(3 447)
(3 782)
(3 465)
(4 157)
(3 512)
(3 512)
(4 036)
0
(1 931)
Other Operating Expenses
0
4 423
2 840
119
0
0
0
0
0
0
0
0
(76)
0
0
0
(452)
0
0
(19 903)
(451)
695
(6 892)
(122)
Operating Income
(4 103)
N/A
(1 527)
+63%
(7 080)
-364%
(11 261)
-59%
(14 584)
-30%
(15 469)
-6%
(16 583)
-7%
(17 378)
-5%
(17 612)
-1%
(18 174)
-3%
(20 334)
-12%
(24 116)
-19%
(28 050)
-16%
(39 020)
-39%
(44 150)
-13%
(51 260)
-16%
(66 892)
-30%
(57 689)
+14%
(53 064)
+8%
(39 191)
+26%
(19 568)
+50%
(21 747)
-11%
(18 329)
+16%
(14 931)
+19%
Pre-Tax Income
Interest Income Expense
(6 975)
(11 821)
(9 533)
(9 150)
(4 981)
579
554
174
(291)
(788)
(1 325)
(1 529)
(1 741)
(2 742)
(6 151)
(7 887)
(5 175)
(4 207)
(1 754)
(253)
(4 631)
(5 260)
(4 741)
(4 293)
Non-Reccuring Items
4 423
0
0
0
0
0
0
0
0
0
0
0
2
0
(45)
(36)
(3 361)
(5 321)
(10 856)
(10 899)
(8 781)
(8 735)
0
(2 961)
Gain/Loss on Disposition of Assets
3
(2)
(2)
0
(5)
0
21
10
(11)
0
0
(41)
(14)
100
70
0
85
(361)
(1 228)
(1 139)
(2 207)
(2 348)
0
(1 558)
Total Other Income
0
(6)
(7)
(10)
(7)
(0)
3
3
(23)
(38)
(63)
(34)
122
131
142
3 019
324
320
311
(2 831)
1 181
1 188
209
1 854
Pre-Tax Income
(6 651)
N/A
(13 356)
-101%
(16 623)
-24%
(20 421)
-23%
(19 577)
+4%
(14 891)
+24%
(16 005)
-7%
(17 190)
-7%
(17 937)
-4%
(19 000)
-6%
(21 721)
-14%
(25 719)
-18%
(29 682)
-15%
(41 532)
-40%
(50 134)
-21%
(56 164)
-12%
(75 018)
-34%
(67 258)
+10%
(66 590)
+1%
(54 314)
+18%
(34 007)
+37%
(36 901)
-9%
(22 861)
+38%
(21 889)
+4%
Net Income
Tax Provision
(47)
(47)
(47)
(47)
(73)
(73)
(73)
(73)
688
0
688
688
1 613
1 638
1 572
1 597
(141)
(194)
(157)
0
(29)
(29)
(0)
0
Income from Continuing Operations
(6 698)
(13 403)
(16 670)
(20 468)
(19 650)
(14 964)
(16 078)
(17 263)
(17 248)
(18 312)
(21 033)
(25 031)
(28 069)
(39 894)
(48 561)
(54 567)
(75 159)
(67 452)
(66 748)
(54 496)
(34 036)
(36 930)
(22 862)
(21 890)
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1 465
1 633
1 735
1 940
Net Income (Common)
(6 698)
N/A
(13 403)
-100%
(16 670)
-24%
(20 468)
-23%
(19 650)
+4%
(14 964)
+24%
(16 078)
-7%
(17 263)
-7%
(17 248)
+0%
(18 312)
-6%
(21 033)
-15%
(25 031)
-19%
(28 069)
-12%
(39 894)
-42%
(48 561)
-22%
(54 567)
-12%
(75 159)
-38%
(73 151)
+3%
(84 845)
-16%
(74 018)
+13%
(32 571)
+56%
(35 297)
-8%
(8 729)
+75%
(6 127)
+30%
EPS (Diluted)
-650.33
N/A
-881.79
-36%
-1 035.39
-17%
-1 312.01
-27%
-1 267.74
+3%
-935.21
+26%
-913.53
+2%
-1 003.65
-10%
-1 071.32
-7%
-1 592.34
-49%
-631.2
+60%
-738.8
-17%
-833.92
-13%
-1 150.74
-38%
-1 400.76
-22%
-1 568.96
-12%
-2 984.97
-90%
-1 997.42
+33%
-2 315.76
-16%
-2 018.6
+13%
-889.35
+56%
-962.62
-8%
-237.46
+75%
-163.8
+31%

See Also

Discover More